Skip to main content
NYSE:PRSP

Perspecta Competitors

$29.34
0.00 (0.00 %)
(As of 05/6/2021)
Add
Compare
Today's Range
$29.34
$29.35
50-Day Range
$29.00
$29.34
52-Week Range
$17.36
$29.62
Volume55,093 shs
Average Volume2.20 million shs
Market Capitalization$4.73 billion
P/E RatioN/A
Dividend Yield0.95%
Beta1.46

Competitors

Perspecta (NYSE:PRSP) Vs. STNE, ZEN, PAGS, GDRX, ATHM, and ZNGA

Should you be buying PRSP stock or one of its competitors? Companies in the industry of "data processing & preparation" are considered alternatives and competitors to Perspecta, including StoneCo (STNE), Zendesk (ZEN), PagSeguro Digital (PAGS), GoodRx (GDRX), Autohome (ATHM), and Zynga (ZNGA).

StoneCo (NASDAQ:STNE) and Perspecta (NYSE:PRSP) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, risk, profitability, analyst recommendations and valuation.

Insider & Institutional Ownership

61.5% of StoneCo shares are held by institutional investors. Comparatively, 76.2% of Perspecta shares are held by institutional investors. 14.8% of Perspecta shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current recommendations and price targets for StoneCo and Perspecta, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
StoneCo05702.58
Perspecta05002.00

StoneCo currently has a consensus price target of $66.20, indicating a potential upside of 10.87%. Perspecta has a consensus price target of $26.45, indicating a potential downside of 9.85%. Given StoneCo's stronger consensus rating and higher possible upside, research analysts clearly believe StoneCo is more favorable than Perspecta.

Profitability

This table compares StoneCo and Perspecta's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
StoneCo26.05%9.87%3.69%
Perspecta-16.16%23.57%5.97%

Volatility & Risk

StoneCo has a beta of 2.4, indicating that its share price is 140% more volatile than the S&P 500. Comparatively, Perspecta has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500.

Earnings & Valuation

This table compares StoneCo and Perspecta's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
StoneCo$626.01 million29.96$203.54 million$0.7086.77
Perspecta$4.50 billion1.05$-676,000,000.00$2.0514.31

StoneCo has higher earnings, but lower revenue than Perspecta. Perspecta is trading at a lower price-to-earnings ratio than StoneCo, indicating that it is currently the more affordable of the two stocks.

Summary

StoneCo beats Perspecta on 8 of the 14 factors compared between the two stocks.

Zendesk (NYSE:ZEN) and Perspecta (NYSE:PRSP) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, risk, profitability, analyst recommendations and valuation.

Insider & Institutional Ownership

97.4% of Zendesk shares are held by institutional investors. Comparatively, 76.2% of Perspecta shares are held by institutional investors. 4.3% of Zendesk shares are held by company insiders. Comparatively, 14.8% of Perspecta shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current recommendations and price targets for Zendesk and Perspecta, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Zendesk021102.85
Perspecta05002.00

Zendesk currently has a consensus price target of $153.8571, indicating a potential upside of 15.73%. Perspecta has a consensus price target of $26.45, indicating a potential downside of 9.85%. Given Zendesk's stronger consensus rating and higher possible upside, research analysts clearly believe Zendesk is more favorable than Perspecta.

Profitability

This table compares Zendesk and Perspecta's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Zendesk-19.24%-22.55%-6.13%
Perspecta-16.16%23.57%5.97%

Volatility & Risk

Zendesk has a beta of 1.27, indicating that its share price is 27% more volatile than the S&P 500. Comparatively, Perspecta has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500.

Earnings & Valuation

This table compares Zendesk and Perspecta's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zendesk$816.42 million19.62$-169,650,000.00($1.19)-113.44
Perspecta$4.50 billion1.05$-676,000,000.00$2.0514.31

Zendesk has higher earnings, but lower revenue than Perspecta. Zendesk is trading at a lower price-to-earnings ratio than Perspecta, indicating that it is currently the more affordable of the two stocks.

Summary

Perspecta beats Zendesk on 8 of the 14 factors compared between the two stocks.

PagSeguro Digital (NYSE:PAGS) and Perspecta (NYSE:PRSP) are both business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, risk, profitability, analyst recommendations and valuation.

Insider & Institutional Ownership

58.5% of PagSeguro Digital shares are held by institutional investors. Comparatively, 76.2% of Perspecta shares are held by institutional investors. 14.8% of Perspecta shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current recommendations and price targets for PagSeguro Digital and Perspecta, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
PagSeguro Digital001003.00
Perspecta05002.00

PagSeguro Digital currently has a consensus price target of $59.50, indicating a potential upside of 41.46%. Perspecta has a consensus price target of $26.45, indicating a potential downside of 9.85%. Given PagSeguro Digital's stronger consensus rating and higher possible upside, research analysts clearly believe PagSeguro Digital is more favorable than Perspecta.

Profitability

This table compares PagSeguro Digital and Perspecta's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PagSeguro Digital21.01%8.33%8.95%
Perspecta-16.16%23.57%5.97%

Volatility & Risk

PagSeguro Digital has a beta of 1.64, indicating that its share price is 64% more volatile than the S&P 500. Comparatively, Perspecta has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500.

Earnings & Valuation

This table compares PagSeguro Digital and Perspecta's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PagSeguro Digital$1.39 billion9.98$346.04 million$1.0838.95
Perspecta$4.50 billion1.05$-676,000,000.00$2.0514.31

PagSeguro Digital has higher earnings, but lower revenue than Perspecta. Perspecta is trading at a lower price-to-earnings ratio than PagSeguro Digital, indicating that it is currently the more affordable of the two stocks.

Summary

PagSeguro Digital beats Perspecta on 9 of the 14 factors compared between the two stocks.

GoodRx (NASDAQ:GDRX) and Perspecta (NYSE:PRSP) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, risk, profitability, analyst recommendations and valuation.

Earnings & Valuation

This table compares GoodRx and Perspecta's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GoodRx$388.22 million31.30$66.05 millionN/AN/A
Perspecta$4.50 billion1.05$-676,000,000.00$2.0514.31

GoodRx has higher earnings, but lower revenue than Perspecta.

Insider & Institutional Ownership

43.4% of GoodRx shares are held by institutional investors. Comparatively, 76.2% of Perspecta shares are held by institutional investors. 14.8% of Perspecta shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares GoodRx and Perspecta's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
GoodRxN/AN/AN/A
Perspecta-16.16%23.57%5.97%

Analyst Recommendations

This is a summary of current recommendations and price targets for GoodRx and Perspecta, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
GoodRx16802.47
Perspecta05002.00

GoodRx currently has a consensus price target of $50.8667, indicating a potential upside of 63.87%. Perspecta has a consensus price target of $26.45, indicating a potential downside of 9.85%. Given GoodRx's stronger consensus rating and higher possible upside, research analysts clearly believe GoodRx is more favorable than Perspecta.

Summary

GoodRx beats Perspecta on 6 of the 11 factors compared between the two stocks.

Autohome (NYSE:ATHM) and Perspecta (NYSE:PRSP) are both computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations.

Earnings & Valuation

This table compares Autohome and Perspecta's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Autohome$1.21 billion9.47$459.65 million$4.1022.16
Perspecta$4.50 billion1.05$-676,000,000.00$2.0514.31

Autohome has higher earnings, but lower revenue than Perspecta. Perspecta is trading at a lower price-to-earnings ratio than Autohome, indicating that it is currently the more affordable of the two stocks.

Dividends

Autohome pays an annual dividend of $0.85 per share and has a dividend yield of 0.9%. Perspecta pays an annual dividend of $0.28 per share and has a dividend yield of 1.0%. Autohome pays out 20.7% of its earnings in the form of a dividend. Perspecta pays out 13.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Autohome has raised its dividend for 1 consecutive years and Perspecta has raised its dividend for 2 consecutive years. Perspecta is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Risk and Volatility

Autohome has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500. Comparatively, Perspecta has a beta of 1.46, suggesting that its share price is 46% more volatile than the S&P 500.

Institutional and Insider Ownership

76.2% of Perspecta shares are owned by institutional investors. 5.7% of Autohome shares are owned by insiders. Comparatively, 14.8% of Perspecta shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Autohome and Perspecta's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Autohome39.58%23.40%18.18%
Perspecta-16.16%23.57%5.97%

Analyst Ratings

This is a breakdown of current ratings and target prices for Autohome and Perspecta, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Autohome12602.56
Perspecta05002.00

Autohome currently has a consensus price target of $106.2167, suggesting a potential upside of 15.49%. Perspecta has a consensus price target of $26.45, suggesting a potential downside of 9.85%. Given Autohome's stronger consensus rating and higher possible upside, equities analysts plainly believe Autohome is more favorable than Perspecta.

Summary

Autohome beats Perspecta on 9 of the 17 factors compared between the two stocks.

Zynga (NASDAQ:ZNGA) and Perspecta (NYSE:PRSP) are both consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations.

Earnings and Valuation

This table compares Zynga and Perspecta's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zynga$1.32 billion8.55$41.92 million($0.06)-174.00
Perspecta$4.50 billion1.05$-676,000,000.00$2.0514.31

Zynga has higher earnings, but lower revenue than Perspecta. Zynga is trading at a lower price-to-earnings ratio than Perspecta, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Zynga has a beta of 0.26, indicating that its stock price is 74% less volatile than the S&P 500. Comparatively, Perspecta has a beta of 1.46, indicating that its stock price is 46% more volatile than the S&P 500.

Insider and Institutional Ownership

69.6% of Zynga shares are owned by institutional investors. Comparatively, 76.2% of Perspecta shares are owned by institutional investors. 9.4% of Zynga shares are owned by company insiders. Comparatively, 14.8% of Perspecta shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Zynga and Perspecta's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Zynga-1.72%-2.06%-1.07%
Perspecta-16.16%23.57%5.97%

Analyst Ratings

This is a breakdown of current ratings and target prices for Zynga and Perspecta, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Zynga111602.83
Perspecta05002.00

Zynga currently has a consensus price target of $12.2763, suggesting a potential upside of 19.07%. Perspecta has a consensus price target of $26.45, suggesting a potential downside of 9.85%. Given Zynga's stronger consensus rating and higher possible upside, equities analysts plainly believe Zynga is more favorable than Perspecta.

Summary

Perspecta beats Zynga on 8 of the 14 factors compared between the two stocks.


Perspecta Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
StoneCo logo
STNE
StoneCo
1.5$60.74flat$18.34 billion$626.01 million99.57Gap Down
Zendesk logo
ZEN
Zendesk
1.7$134.99flat$15.69 billion$816.42 million-85.98
PagSeguro Digital logo
PAGS
PagSeguro Digital
1.7$42.07flat$13.64 billion$1.39 billion50.69
GoodRx logo
GDRX
GoodRx
1.7$30.99flat$11.92 billion$388.22 million0.00Earnings Announcement
Autohome logo
ATHM
Autohome
1.9$90.86flat$11.60 billion$1.21 billion22.55Unusual Options Activity
Zynga logo
ZNGA
Zynga
1.7$10.44flat$10.98 billion$1.32 billion-348.00
Five9 logo
FIVN
Five9
1.6$166.25flat$10.97 billion$328.01 million-313.67Unusual Options Activity
Proofpoint logo
PFPT
Proofpoint
1.6$171.53flat$9.86 billion$888.19 million-62.37
Pegasystems logo
PEGA
Pegasystems
1.8$119.67flat$9.49 billion$911.38 million-147.74
DXC Technology logo
DXC
DXC Technology
1.4$37.02flat$9.36 billion$19.58 billion-2.43
Globant logo
GLOB
Globant
1.6$216.96flat$8.51 billion$659.33 million172.19Earnings Announcement
Change Healthcare logo
CHNG
Change Healthcare
1.0$23.00flat$7.00 billion$3.20 billion-41.82
JOYY logo
YY
JOYY
2.7$89.25flat$6.98 billion$3.67 billion6.77Upcoming Earnings
CoreLogic logo
CLGX
CoreLogic
1.9$79.50flat$5.85 billion$1.76 billion27.32
Skillz logo
SKLZ
Skillz
1.6$16.41flat$5.80 billionN/A0.00Gap Down
Upwork logo
UPWK
Upwork
1.4$41.23flat$5.06 billion$300.56 million-164.92Insider Selling
Gap Down
Inovalon logo
INOV
Inovalon
1.2$30.93flat$4.82 billion$642.41 million773.44
CarGurus logo
CARG
CarGurus
1.7$28.42flat$3.25 billion$588.92 million49.00
EVERTEC logo
EVTC
EVERTEC
1.7$43.74flat$3.14 billion$487.37 million33.14
LiveRamp logo
RAMP
LiveRamp
1.7$47.59flat$3.12 billion$380.57 million-36.33Upcoming Earnings
Shutterstock logo
SSTK
Shutterstock
1.8$86.38flat$3.12 billion$650.52 million62.14
8X8 logo
EGHT
8X8
1.8$24.50flat$2.57 billion$446.24 million-14.16Analyst Report
Liberty TripAdvisor logo
LTRPB
Liberty TripAdvisor
0.1$32.04flat$2.41 billion$1.56 billion-8.41Gap Down
SciPlay logo
SCPL
SciPlay
1.6$16.84flat$2.09 billion$465.80 million19.14
Global Blue Group logo
GB
Global Blue Group
0.8$10.87flat$1.96 billionN/A0.00
Yext logo
YEXT
Yext
1.6$12.97flat$1.59 billion$298.83 million-11.68
CSG Systems International logo
CSGS
CSG Systems International
1.9$44.85flat$1.48 billion$996.81 million21.36
trivago logo
TRVG
trivago
1.0$3.78flat$1.29 billion$939.36 million-5.11
So-Young International logo
SY
So-Young International
1.1$8.96flat$963.83 million$165.42 million224.00Upcoming Earnings
Cars.com logo
CARS
Cars.com
1.2$13.68flat$921.89 million$606.68 million-1.11
Tucows logo
TCX
Tucows
0.9$78.06flat$832.71 million$337.14 million88.71
Sohu.com logo
SOHU
Sohu.com
1.4$17.86flat$672.53 million$1.85 billion-4.75
Veritone logo
VERI
Veritone
1.2$18.46flat$558.57 million$49.65 million-9.66
Brightcove logo
BCOV
Brightcove
2.0$14.09flat$546.33 million$184.46 million-38.08
IBEX logo
IBEX
IBEX
1.4$23.08flat$424.40 million$405.14 million27.48
ZIX logo
ZIXI
ZIX
1.9$6.88flat$395.06 million$173.43 million-22.19
Ooma logo
OOMA
Ooma
1.6$16.16flat$375.09 million$151.59 million-80.80
Liberty TripAdvisor logo
LTRPA
Liberty TripAdvisor
1.0$4.90flat$359.46 million$1.56 billion-1.29
GTY Technology logo
GTYH
GTY Technology
1.5$6.38flat$342.36 million$36.44 million-9.11Earnings Announcement
Gap Up
Leaf Group logo
LEAF
Leaf Group
0.9$8.38flat$301.59 million$154.96 million-19.05Analyst Report
NantHealth logo
NH
NantHealth
1.0$2.53flat$284.63 million$95.96 million-5.75
Castlight Health logo
CSLT
Castlight Health
0.7$1.82flat$278.99 million$143.31 million-3.71Gap Down
Renren logo
RENN
Renren
0.5$10.54flat$248.10 million$349.78 million0.00Gap Down
BLCT
BlueCity
1.4$7.10flat$246.71 million$107.18 million0.00
SJ
Scienjoy
1.8$7.01flat$222.12 millionN/A7.70Upcoming Earnings
GSMG
Glory Star New Media Group
0.0$3.67flat$212.44 millionN/A0.00
Innodata logo
INOD
Innodata
0.4$6.60flat$168.96 million$55.86 million-330.00
CooTek (Cayman) logo
CTK
CooTek (Cayman)
1.0$2.12flat$129.78 million$177.88 million-3.66
Fang logo
SFUN
Fang
0.6$11.42flat$102.48 million$219.71 million-2.05
WISeKey International logo
WKEY
WISeKey International
1.8$7.70flat$102.07 million$22.65 million-2.41
This page was last updated on 5/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.